From healthcare design to documentary evidence
In the two previous articles of this series of three technical publications We have addressed how pharmaceutical design should start from risk analysis (QbD) and how architecture, flows and HVAC systems materialize that approach in the plant. In this third and final installment we complete the cycle, entering into the elements that, most frequently, determine the success (or failure) of a validation and regulatory inspection: equipment design, automation, critical support systems and the qualification life cycle.
In the pharmaceutical industry, a facility does not “exist” from a GMP perspective until it is demonstrable, reproducible and defensible through objective evidence.
The equipment as an extension of the installation
In the pharmaceutical and biopharmaceutical environment, equipment is not isolated elements: it is an integral part of the installation and must be designed under the same risk control principles.
This is where standards like ASME BPE (Bioprocessing Equipment) They become a fundamental reference, especially in sterile and biotechnological processes.
Materials and surface finish
Material and finish decisions are not aesthetic; are microbiological and cleaning decisions.
Among the most common criteria are:
- AISI 316L stainless steel, with low carbon content to minimize the risk of intergranular corrosion.
- Controlled surface finish, by mechanical polishing or electropolishing.
- Typical roughness values:
- Ra ≤ 0.8 μm in general pharmaceutical applications.
- Ra ≤ 0.4 μm in biotechnological applications.
The objective is to eliminate microporosities where microorganisms or residues from previous batches can lodge.
Sanitary design and cleaning strategies (CIP/SIP)
A well-designed installation should be able be cleaned and sterilized reproducibly and automatically, without depending on complex manual interventions.
Clean-in-Place (CIP)
The CIP design must avoid:
- stagnation zones,
- Sudden section changes,
- Unnecessary referrals.
The classic rule of sanitary design is still fully valid:
- L/D ratio < 2 to avoid dead legs (the length of a lead should not exceed twice its diameter).
Sterilization-in-Place (SIP)
In systems that require sterilization:
- The equipment must resist saturated steam at 121 °C.
- The design must ensure that all critical points reach the required F₀ lethality value.
- Instrumentation must allow cold spots to be identified and the complete cycle to be validated.
Typical error detected in validation
Technically adequate equipment, but impossible to clean or sterilize homogeneously due to poor sanitary design.
Pharmaceutical water systems: the universal solvent
In the pharmaceutical industry, water is not an auxiliary service: it is a critical raw material. The systems Purified Water (PW) and Water for Injection (WFI) They represent one of the greatest engineering, validation and maintenance challenges.
Distribution loop design (Loops)
The design must systematically avoid any possibility of microbial proliferation. Key principles include:
| Continuous turbulent flow | Maintain a Reynolds number Re > 4000 to avoid low velocity layers near the pipe walls. |
| Drainage slopes | All lines must incorporate slopes (typically 1–2%) that allow complete emptying of the system. |
| Absence of dead arms | Branches to points of use should be as short as possible, following ASME BPE criteria. |
Sanitization strategies
Depending on the type of water, the design must integrate:
- Thermal sanitation, maintaining the WFI loop in continuous circulation at temperatures above 80 °C (self-sanitizing system).
- Chemical or ozone sanitation, especially in PW, with ozone destruction systems using UV lamps before the points of use.
Control and automation systems: when validation is digital
Automation design is as critical as plumbing or HVAC design. A poorly conceived control system can compromise the data integrity and, with it, the release of product.
The usual frame of reference includes: GAMP 5, 21 CFR Part 11 and data integrity requirements (ALCOA+).
Key data integrity principles
Every PLC, SCADA or MES system must guarantee:
- Audit Trail unalterable (who, when and why).
- User management with hierarchical access levels.
- Archiving and recovery secure, with verified backup copies.
Batch control and traceability
The design must allow:
- Real-time data capture.
- Generation of Electronic Batch Record.
- Reduction of human error and acceleration of batch release by the Qualified Person (QP).
The qualification life cycle: from URS to PQ
A pharmaceutical facility is only GMP when it can demonstrate that works as expected. He V model remains the framework for structuring this demonstration.
URS: the origin of everything
The User Requirements Specifications (URS) They are often the most undervalued document and, at the same time, the most decisive.
An effective URS should be Specific, Measurable, Achievable, Relevant and Time-Defined (SMART).
Example: It is not enough to indicate “the system must be fast”.
The correct requirement would be: “the system must process 120 vials/min with a rejection rate of less than 0.05%”.
DQ: detect errors before building them
The Design qualification (DQ) is documented evidence that the proposed design: meets GMP, meets URS, and is validable and maintainable.
It is the optimal time to correct errors that, in construction or operation, would be critical.
IQ, OQ and PQ: the final test
| IQ (Installation Qualification) | Verification that the installed equipment corresponds to that specified: materials, certificates, calibrations. |
| OQ (Operational Qualification) | Confirmation that the system operates within defined limits: alarms, interlocks, operating ranges. |
| PQ (Performance Qualification) | Evidence that the system produces consistent and reproducible results under actual operating conditions, including cleaning and media fills in sterile processes. |
Conclusion: design with evidence in mind
Modern pharmaceutical design does not end with start-up. It ends when the system can be cleaned, controlled, validated, and defended against inspection.
Integrating engineering, automation and validation from the early phases of the project is the only way to build facilities Robust against risk and sustainable in the long term.
Throughout this series we have shown how:
- Quality is designed from risk analysis.
- Layout and HVAC are critical control tools.
- Equipment, automation and qualification turn design into GMP evidence.
If you are planning a new plant or modernizing an existing facility, we can accompany you from the definition of URS to PQ, ensuring regulatory compliance from day one.